Strata Critical Medical (SRTA) Equity Ratio (2019 - 2026)

Strata Critical Medical (SRTA) has 8 years of Equity Ratio data on file, last reported at 0.87 in Q1 2026.

• Quarterly Equity Ratio fell 0.55% year-over-year to 0.87 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.87 (down 0.55% YoY) and the FY2025 annual result came in at 0.86, down 0.84% from the prior year.
• Equity Ratio climbed to 0.87 in Q1 2026 per SRTA's latest filing, from 0.86 in the prior quarter.
• Across five years, Equity Ratio topped out at 0.9 in Q2 2022 and bottomed at 0.79 in Q4 2023.
• The 5-year median for Equity Ratio is 0.84 (2025), against an average of 0.85.
• The widest annual swing landed in 2022, when Equity Ratio jumped 3021.33%; it then fell 9.67% in 2023.
• Tracing SRTA's Equity Ratio over 5 years: stood at 0.84 in 2022, then dropped by 5.93% to 0.79 in 2023, then gained by 8.84% to 0.86 in 2024, then fell by 0.84% to 0.86 in 2025, then climbed by 1.72% to 0.87 in 2026.
• Per Business Quant, the three latest SRTA Equity Ratio figures stand at 0.87 (Q1 2026), 0.86 (Q4 2025), and 0.84 (Q3 2025).

Peer Comparison